SCHEMBL5745205

SCHEMBL5745205

Brc1cccc(-c2ccc[c]c2Br)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.37
RAB9A P51151 4/20 0.37
NPC1 O15118 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
TP53 P04637 1/20 0.37
TSHR P16473 1/20 0.37
ALDH1A1 P00352 5/20 0.36
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
IDO1 P14902 1/20 0.36
METAP2 P50579 1/20 0.36
CYP1A2 P05177 1/20 0.36
HPGD P15428 2/20 0.35
MAPT P10636 2/20 0.35
GAA P10253 2/20 0.35
HK1 P19367 1/20 0.35
HKDC1 Q2TB90 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
MAOA P21397 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4283341 0.81 HSD17B1 (0.45) ALDH1A1CYP1A2HSD17B10
SCHEMBL21647115 0.81 BIRC5 (0.36) MAOBRAB9ANPC1SMN1; SMN2TP53
SCHEMBL11512521 0.81 MAP4K4 (0.46) ALDH1A1MEN1KMT2AMETAP2HPGD
SCHEMBL5182575 0.79 ALDH1A1 (0.50) RAB9ASMN1; SMN2TP53ALDH1A1HPGD
SCHEMBL1431628 0.78 ALDH1A1 (0.41) MAOBRAB9ANPC1SMN1; SMN2TP53
SCHEMBL5085470 0.77 RAB9A (0.37) MAOBRAB9ANPC1SMN1; SMN2TP53
SCHEMBL29398181 0.77 RAB9A (0.50) MAOBRAB9ANPC1SMN1; SMN2TP53
SCHEMBL5805651 0.77 RAB9A (0.50) MAOBRAB9ANPC1SMN1; SMN2TP53
SCHEMBL5584043 0.76 LMNA (0.31) ALDH1A1MAPK1
SCHEMBL28015325 0.75 GABRG2 (0.34) MAOBRAB9ANPC1SMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1720556-A2 NOVEL 2'-C-METHYL NUCLEOSIDE DERIVATIVES Merck & Co., Inc. (US) 2006-11-15 EP claimed
WO-2005084192-A2 NOVEL 2’-C-METHYL NUCLEOSIDE DERIVATIVES MERCK & CO., INC. (US) 2005-09-15 WO claimed
US-5869521-A Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith ADOLOR CORPORATION (US) 1999-02-09 US disclosed